Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Brain Neoplasms 3Cognitive Dysfunction 2Tobacco Use Disorder 1Rectal Neoplasms 1Prostatic Neoplasms 1Neurotoxicity Syndromes 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Lung Neoplasms 1Ependymoma 1Craniopharyngioma 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Tobacco Use Cessation Devices 5Counseling 5Early Intervention, Educational 3Bupropion 3Varenicline 2Nicotine Replacement Therapy 2Nicotine 2Community Health Workers 2Aspirin 2zileuton 1phenethyl isothiocyanate 1phenanthrene tetraol 1phenanthrene 1Zinc Oxide 1Sulindac 1Risk Factors 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Methods 1Memantine 1Gene Expression Profiling 1Fertility 1Ethanol 1Drug Therapy 1Celecoxib 1Calcitriol 14-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Tobacco Use Disorder × Memantine × Clear all
NCT01535040 2021-09-28

Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking

Wake Forest University Health Sciences

Phase 2 Completed
130 enrolled 12 charts
BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Tobacco Use Disorder, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡